Coherus BioSciences, Inc. Quarterly Marketable Securities, Current in USD from Q1 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Coherus BioSciences, Inc. quarterly Marketable Securities, Current history and growth rate from Q1 2017 to Q4 2023.
  • Coherus BioSciences, Inc. Marketable Securities, Current for the quarter ending December 31, 2023 was $14.9M, a 88.4% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $14.9M -$113M -88.4% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $50.8M Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $71.8M Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $112M Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $128M Dec 31, 2022 10-K 2024-03-15
Q3 2021 $108M -$103M -48.7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $125M -$107M -46.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $140M Mar 31, 2021 10-Q 2021-05-06
Q3 2020 $211M +$206M +3823% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $232M +$226M +3771% Jun 30, 2020 10-Q 2020-08-06
Q4 2019 $0 $0 Dec 31, 2019 10-Q 2020-08-06
Q3 2019 $5.38M -$10.6M -66.3% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $5.99M -$23.8M -79.9% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $14.9M +$1.78M +13.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-08
Q3 2018 $16M +$1.48M +10.2% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $29.8M -$15.2M -33.7% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $13.1M -$36.8M -73.7% Mar 31, 2018 10-Q 2018-05-10
Q3 2017 $14.5M Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $45M Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $49.9M Mar 31, 2017 10-Q 2017-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.